PATENT CLAIM ANALYSIS

Application Number: 16315263
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-07
Patent Classification: ["514", "275000"]

Abstract:
Provided is a pharmaceutical composition for preventing and treating tumors, the pharmaceutical composition including an imidazooxazole derivative compound, a solvate, a stereoisomer, or a pharmaceutically acceptable salt thereof as an active ingredient. The pharmaceutical composition is administered to an entity which has developed a tumor or is in danger of developing a tumor, and thus tumors can be prevented or treated.

Claim (Index 2):
The compound or the solvate, stereoisomer, or pharmaceutically acceptable salt thereof of  claim 1 , wherein,\n when X is O, R 1  is hydrogen, fluoro, methoxy, hydroxyl, or a combination thereof, R 2 , R 3 , and R 4  are each independently hydrogen, tert-butyloxycarbonyl, ethyl, methyl, or benzyl, and R 5  is phenyl unsubstituted or substituted with one or more substituents, wherein the one or more substituents being selected from the group consisting of methyl, ethyl, fluoro, trifluoromethyl, hydroxyl, methoxy, nitro, amide, urea, and acetyl.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 99.0
- Lexical Diversity: 1.51111
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12274834', '14436145', '15841902', '13509442', '13506510']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.803524214049192
- 35 USC 102 Novelty (BERT): 0.5406072486047148
- Combined Prediction Score: 0.7772325175047443
- Mean Citation Score: 333.91248600000006
- Max Citation Score: 374.03793
- Similarity Product: 288.06453366150504

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test